Unusual treatment of Kasabach-Merritt syndrome secondary to hepatic hemangioma: embolization with bleomycin


BOZKAYA H. , ÇİNAR C. , ÜNALP Ö. V. , PARILDAR M. , Oran I.

WIENER KLINISCHE WOCHENSCHRIFT, vol.127, pp.488-490, 2015 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 127
  • Publication Date: 2015
  • Doi Number: 10.1007/s00508-014-0675-5
  • Title of Journal : WIENER KLINISCHE WOCHENSCHRIFT
  • Page Numbers: pp.488-490
  • Keywords: Kasabach-Merritt syndrome, Liver hemangiomas, Transarterial chemoembolization, Bleomycin, Lipiodol, TRANSCATHETER ARTERIAL EMBOLIZATION, CAVERNOUS HEMANGIOMA, LIVER

Abstract

Kasabach-Merritt syndrome (KMS) is a rare complication of cavernous hemangiomas characterized with anemia, thrombocytopenia, and consumption coagulopathy. This syndrome usually develops due to superficial soft tissue hemangiomas in infancy and childhood. KMS developing secondarily to hepatic hemangioma is very rare. In this report, we aimed to present the treatment of KMS developing secondarily to giant cavernous hemangioma of the liver with transarterial chemoembolization using bleomycin.